Characterization of changes in FibroTest values during treatment with tenofovir alfenamide (TAF) Or tenofovir disproxil fumarate (TDF) in patients with CHB
No Thumbnail Available
Date
2016-10
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Description
Bu çalışma, 11-15 Kasım 2016 tarihlerinde Boston[Amerika Birleşik Devletleri]’ da düzenlenen 67. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) Kongresi‘nde bildiri olarak sunulmuştur.
Keywords
Gastroenterology & hepatology
Citation
Izumi, N, vd. (2016). "Characterization of changes in FibroTest values during treatment with tenofovir alfenamide (TAF) Or tenofovir disproxil fumarate (TDF) in patients with CHB". Hepatology, 64(Supplement 1), 941A-942A.